IP Group — Roadmap to value
IP Group made good progress in crystallising its portfolio values through exits, with proceeds of £183m collected in FY24, most notably from the...
265 Views
IP Group — Examining Istesso’s Phase IIb trial results
Istesso, IP Group’s largest private life sciences holding (c 11% of end-June 2024 portfolio value), has announced the results of its Phase IIb...
152 Views
IP Group - Record exit underpinning the NAV
IP Group’s realisation activity has picked up notably in the months leading up to the company’s interim results publication in September,...
333 Views
IP Group - Management sees positive portfolio momentum
IP Group reported broadly stable private portfolio values in H124, assisted by the positive revaluation of Featurespace, an AI-powered fraud and...
373 Views
IP Group - Novo Holdings invests in Oxford Nanopore
IP Group’s largest life sciences holding at end-2023, Oxford Nanopore (ONT), which developed a new generation of nanopore-based sensing technology,...
310 Views